Mikosz, Christina A.

Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin—Final Report

Layden, J. E., Ghinai, I., Pray, I., Kimball, A., Layer, M., Tenforde, M. W., Navon, L., Hoots, B., Salvatore, P. P., Elderbrook, M., et al. (2020) · New England Journal of Medicine

Smoking Behavior and CessationPoisoning and overdose treatments

Cited by 911

Severe pulmonary disease associated with electronic-cigarette–product use—interim Guidance

Schier, J. G., Meiman, J. G., Layden, J., Mikosz, C. A., VanFrank, B., King, B. A., Salvatore, P. P., Weissman, D. N., Thomas, J., Melstrom, P. C., et al. (2019) · MMWR. Morbidity and Mortality Weekly Report

Smoking Behavior and CessationPoisoning and overdose treatments

Cited by 246

Assessment of Annual Cost of Substance Use Disorder in US Hospitals

Peterson, C., Li, M., Xu, L., Mikosz, C. A., & Luo, F. (2021) · JAMA Network Open

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 200

Ubiquitin modification of serum and glucocorticoid-induced protein kinase-1 (SGK-1)

Brickley, D. R., Mikosz, C. A., Hagan, C. R., & Conzen, S. D. (2002) · Journal of Biological Chemistry

Ubiquitin and proteasome pathwaysProtein Kinase Regulation and GTPase Signaling

Cited by 94

Medical Costs of Substance Use Disorders in the US Employer-Sponsored Insurance Population

Li, M., Peterson, C., Xu, L., Mikosz, C. A., & Luo, F. (2023) · JAMA Network Open

Substance Abuse Treatment and OutcomesHealth Systems, Economic Evaluations, Quality of Life

Cited by 35